ABIN309588
antibody from antibodies-online
Targeting: CHEK2
bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN309588 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Checkpoint Kinase 2 (CHEK2) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- The immunogen for anti-CHEK2 antibody: synthetic peptide directed towards the N terminal of human CHEK2
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Antigen sequence
MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQS
QGISS SSTSTMPNSS- Epitope
- N-Term
- Vial size
- 50 μg
- Concentration
- 1mg/mL
- Storage
- -20°C
- Handling
- Avoid repeated freeze-thaw cycles.
Submitted references Antiangiogenic and radiotherapy for cancer treatment.
Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival.
Parkinsonism and midbrain dysfunction after shunt placement for obstructive hydrocephalus.
Kobayashi H, Lin PC
Histology and histopathology 2006 Oct;21(10):1125-34
Histology and histopathology 2006 Oct;21(10):1125-34
Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival.
Ribeiro-Silva A, Moutinho MA, Moura HB, Vale FR, Zucoloto S
Histology and histopathology 2006 Apr;21(4):373-82
Histology and histopathology 2006 Apr;21(4):373-82
Parkinsonism and midbrain dysfunction after shunt placement for obstructive hydrocephalus.
Yomo S, Hongo K, Kuroyanagi T, Kobayashi S
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2006 Apr;13(3):373-8
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2006 Apr;13(3):373-8
No comments: Submit comment
No validations: Submit validation data